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predictive variables, respectively directly and inversely related to CFRD develop-
ment (pseudo R2 for the model: 0.581, p< 0.001). Glycated hemoglobin and base-
line glucose concentrations were directly related with outcome at univariate analysis
whereas c-peptide concentrations were inversely related. In contrast, no relationship
emerged between insulin-sensitivity indexes and outcome. Anthropometric (weight,
height z scores, BMI) and pulmonary function indexes were also unrelated.
Conclusions: Defects in insulin secretion are determinants of subsequent CFRD
development. The evaluation of insulin concentrations during OGTT may be helpful
in CFRD prediction.
This study has been supported by a grant of Fondazione per la Ricerca sulla Fibrosi
Cistica ONLUS – Verona (Progetto FFC 16/2005).
*This Poster has been presented also as Oral Communication, by invitation of
the Scientiﬁc Committee
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Objectives:
1. To study the effectiveness and reliability of the continuous monitoring of blood
glucose (CGMS) in CF patients, to be able to identify at an early stage any
condition of glycemic intolerance (IGT) or even diabetes.
2. To evaluate if the pre-diabetic treatment with insulin may lead to an improvement
of CF pts glyco-metabolic control and of other clinical parameters such as BMI
and FEV1.
Materials and Methods: We evaluated 10 CF pts (5 M and 5 F) with standard
OGTT or altered baseline glycemic values. These pts had also shown a decrease in
FEV1 and BMI values during the 2 years before the beginning of the study.
A microdialysis ﬁber was inserted subcutaneously into the periumbelical region
and perfused with a buffer solution. Glucose concentrations in the dialysate were
measured every 3 minutes by the glucose sensor over a 48-h period, during which
6 capillary blood samples were also collected before and after the 3 mean meals to
evaluate the correlation between CGMS and traditional methods. The pts diagnosed
for Cystic Fibrosis Related Diabetes (CFRD) as a result of monitoring, began
insulinic therapy. After a follow-up period of 14 months glycaemia, FEV1 and
BMI were evaluated again for each of them.
Results: Both the insertion of the ﬁber and the wearing of the device were well
tolerated by the pts. Subcutaneous glucose levels were well correlated with capillary
glucose measurements (r = 0.88, P< 0.001) over a wide range (45–250mg/dl) for
up to 48 h. An analysis of 120 relevations showed a linear relationship between
the CGMS and serial capillary blood glucose levels, and 98.33% of the data fell
in the A and B regions of the error grid analysis. The results of CGMS for 48
hours conﬁrmed the presence of IGT in all pts and identiﬁed early CFRD in 6 pts
who had glycemic peaks > 200mg/dl. After they were given insulinic therapy they
showed an improvement of the glyco-metabolic control and an increasement of 6%
of BMI values during the 14 months of follow up. FEV1% values were unchanged.
Conclusions: The CGMS demonstrated high reliability and provided much more
informations about glycemic excursions and glucose trends than the traditional
diagnostic methods, making it possible to identify earlier the CFRD in CF pts and
begin as soon as possible an individual insulinic treatment.
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We basically describe the case of a CF pt that developed fatal EBV related
lymphoma 4 months after lung transplantation. A 17 years old female CF pt
underwent bilateral sequential lung transplantation uneventful in May 2006. All
other recipients from the same multi-organ donor are currently alive and well
with no evidence of lymphoproliferative disease. Standard immunosuppression was
instituted with Tacrolimus, Azathioprine and Prednisone. In October 2006 the pt
was readmitted to the hospital with a decrease of FEV1 of > 10%, increased
inﬂammation index, anemia, low platelets count, fever (39−40º). Chest x-ray and
CT showed diffused peribronchial inﬁltrates. Physical and abdominal examination
was negative; abdominal echography was also negative. Wide spectrum antibiotics
were administered. Bacteriology, virology and fungal exams were performed, but
all proved negative, including the search for EBV and CMV. Still, high fever
(39−40º) persisted along with lymphocytosis and neutropenia. With the suspect
of CMV infection Ganciclovir (10mg/kg/die IV) and immunoglobulins were
administered. Immunosuppression was discontinued. Ten days after admission,
without any clinical improvement, the spleen became palpable and a laterocervical
lymphonodus evident. A biopsy was immediately performed; abdominal echography
and CT were also performed. Multiple lymphadenopaties were revealed, along with
hepatosplenomegaly and moderate pleural effusion. EBV related lymphoma was
suspected on the basis of these ﬁndings and Retuximab therapy was started. The
clinical setting deteriorated over the following days and multiple organ failure
developed. The patient died on the 18th day after admission.
Necropsy conﬁrmed clinical ﬁndings, and in situ hybridization conﬁrmed the
expression of EBV genome in over 90% of the large B Lymphoma cells.
We believe it is important to be aware that Lymphoma can develop also in the early
postoperative period after lung transplantation. Although it is common knowledge
that lymphoproliferative disease can occur in as much as 10% of lung transplanted
patients, this usually occurs years after the transplant. The early occurrence of this
dramatic complication certainly entails exceptional severity and difﬁcult diagnostic
problems, which might be facilitated by its awareness.
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Colonization of cystic ﬁbrosis (CF) airways with Burkolderia cepacia complex
(Bcc) is associated with an accelerated pulmonary deterioration and increased
mortality. Bcc sepsis is one of the most dramatic events that can occur in a patient
chronically infected.
We describe the case of a 62-year-old woman with CF (diagnosed at the age of
50), with type II chronic respiratory insufﬁciency in long term oxygen therapy and
nocturnal non-invasive ventilation, severe obstructive respiratory impairment (FEV1
29% of the predicted value), totiresistant B. cenocepacia (genomovar III) chronic
pulmonary infection. On July 2007 she presented with obnubilation, worsened gen-
eral and respiratory conditions and pyrexia; blood culture detected Bcc septicaemia.
The organism was resistant to all antibiotics singly and synergically in vitro tested,
and the sepsis occurred while she was being treated with intravenous ceftazidim
and oral co-trimoxazole.
Multiple antibiotics, including levoﬂoxacin per os, ceftazidim i.v., meropenem as
continuous intravenous infusion associated with high-dose i.v. methylprednisolone
were administered.
Despite the fact that Bcc was resistant to all tested antibiotics, her clinical conditions
progressively improved and she overcame the acute Bcc sepsis.
The exact mortality rate associated with Bcc septicaemia in CF patients is not
known, but it is thought to approach 100%.
We speculate that the intensive antibacterial therapy, in particular the continuous
intravenous infusion of meropenem, and the anti-inﬂammatory effects of high-dose
corticosteroids, could signiﬁcantly contribute to the survival of the patient.
Moreover, the favourable outcome of this case highlights that the resistance to
antibiotics detected in vitro does not always correspond to clinical inefﬁcacy.
P62 FUNCTIONAL ENDOSCOPIC SINUS SURGERY (FESS) IN
PATIENTS WITH CYSTIC FIBROSIS (CF)
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Objective: To determine the effectiveness of FESS through the reduction of
symptoms and the improvement of related clinical parameters in children and young
adults with CF and sinonasal disease (SND).
Materials and methods: 12 children and young adults (15 years median age;
range 7–38) with medically refractory SND were examined before and after FESS.
The main outcome measures were sinonasal symptoms, spirometric values (forced
expiratory volume in 1 second, FEV1, and peak expiratory ﬂux, PEF), and number
of hospitalizations. The extent of polyposis was graded endoscopically and on
computer tomography images. The sinonasal symptoms were inquired through a
questionnaire pre- and postoperatively.
Results: The mean follow up time after surgery was 15.1 months. Postoperatively,
polyp recurrence was seen in 5 pts of 12. Before surgery, bilateral nasal polyposis
was an endoscopic ﬁnding in 11 pts of 12, and 50% of them had polyps occluding
the middle meatus (grade 2 polyposis). 4 pts had undergone previous polypectomy
in other centers. The symptoms complained were nasal obstruction (100%), nasal
discharge and postnasal drip (67%) and anosmy (50%). Only 2 pts complained
headache. After FESS, 4 pts reported no nasal obstruction and marked decline in
the frequency of nasal discharge and postnasal drip (25%). Headache shows no
improvement.
Spirometric values and the number of pulmonary exacerbations were found to be
related to the severity degree of lung disease. On the basis of these observations CF
